Periprocedural Management of Patients on Dabigatran Etexilate Treatment

References

1. 1.↵
   1. Siddiqui FM,
   2. Qureshi AI

   . Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation. Expert Opin Pharmacother 2010;11:1403–11

   CrossRefPubMed
2. 2.↵
   1. Connolly SJ,
   2. Ezekowitz MD,
   3. Yusuf S,
   4. et al

   . Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139–51

   CrossRefPubMed
3. 3.↵
   1. van Ryn J,
   2. Stangier J,
   3. Haertter S,
   4. et al

   . Dabigatran etexilate: a novel, reversible, oral direct thrombin inhibitor—interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010;103:1116–27. Epub 2010 Mar 29

   PubMedWeb of Science
4. 4.↵
   CinicalTrials.gov. Interventional Management of Stroke (IMS) III Trial (IMS III). http://clinicaltrials.gov/ct2/show/NCT00359424. Accessed September 23, 2011